Alnylam Pharmaceuticals (ALNY) Deferred Taxes (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly Deferred Taxes of $9.3 million for Q1 2026, down 3.41% year-on-year from $9.6 million in Q1 2025, and up 134.27% on a QoQ basis from -$27.2 million in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 5 years of Deferred Taxes data on file, last reported at $9.3 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes fell 3.41% year-over-year to $9.3 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (up 97.41% YoY), and the FY2025 full-year result was -$2.2 million, up 97.94% from the prior year.
- Deferred Taxes for Q1 2026 stood at $9.3 million, up from -$27.2 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $9.7 million in Q2 2025 and bottomed at -$107.4 million in Q4 2024.
- The 3-year median for Deferred Taxes is $454000.0 (2024), against an average of -$11.1 million.
- The widest annual swing landed in 2025, when Deferred Taxes jumped 3534.36%; it then fell 3.41% in 2026.
- A 3-year view of Deferred Taxes shows it stood at -$107.4 million in 2024, then surged by 74.7% to -$27.2 million in 2025, then surged by 134.27% to $9.3 million in 2026.
- The last three Deferred Taxes figures came in at $9.3 million (Q1 2026), -$27.2 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.31 Mn |
| Dec 31, 2025 | -27.17 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | 9.74 Mn |
| Mar 31, 2025 | 9.64 Mn |
| Dec 31, 2024 | -107.39 Mn |
| Sep 30, 2024 | -163,000.00 |
| Jun 30, 2024 | 340,000.00 |
| Mar 31, 2024 | 454,000.00 |
| Dec 31, 2010 | 10.88 Mn |
| Sep 30, 2010 | 83,000.00 |
| Jun 30, 2010 | -85,000.00 |
| Mar 31, 2010 | -131,000.00 |
| Dec 31, 2009 | -5.19 Mn |
| Sep 30, 2009 | 281,000.00 |